Imagen de Portada

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Hanna L. Kleiboeker, Jillian L. Descourouez, Chris M. Saddler, David Al‐Adra, John P. Rice, Margaret R. Jorgenson
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
por: Margaret R. Jorgenson, et al.
Publicado: (2024)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
por: John‐Anthony Coppola, et al.
Publicado: (2025)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
por: Suneri J. Amin, et al.
Publicado: (2025)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
por: Abdallah Mughrabi, et al.
Publicado: (2026)

Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
por: Florence Runyo, et al.
Publicado: (2025)

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025)

Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
por: Natasha Banga, et al.
Publicado: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)

De Novo Psoriasis Following Belatacept Therapy in Transplant Recipients: Case Series
por: Grace Y. Im, et al.
Publicado: (2025)

Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
por: Eishan Ashwat, et al.
Publicado: (2025)

Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease
por: Domitille Erard, et al.
Publicado: (2024)

Reduced Functional Status among Kidney Transplant Recipients over Time and Associated Risks Post‐Transplant
por: Sage L. Dixon, et al.
Publicado: (2025)

Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients
por: Emilie Høegholm Ernst Lauridsen, et al.
Publicado: (2026)

Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
por: Madeleine R. Heldman, et al.
Publicado: (2024)

High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic‐Associated Steatotic Liver Disease
por: Emily A. Leven, et al.
Publicado: (2026)

Neighborhood Deprivation Linked to Medication Level Variability in Liver Transplant Recipients
por: Laila Fozouni, et al.
Publicado: (2025)

Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once‐Daily Tacrolimus Formulations: The BITACORA Study
por: Amado Andrés, et al.
Publicado: (2026)

Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
por: Song Peng Ang, et al.
Publicado: (2025)

Optimizing Anesthesia Management in Liver Transplantation With Use of Real Time Frontal Electroencephalogram
por: Gabriel Rice, et al.
Publicado: (2025)

Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
por: Lien‐Chung Wei, et al.
Publicado: (2025)

Exploring the Viability of Matching Marginal Donors With Low Renal Function Recipients in Liver Transplantation
por: Miho Akabane, et al.
Publicado: (2025)

Tailoring Liver Transplant Decisions: How Donor–Recipient Age Matching Influences Outcomes
por: Abiha Abdullah, et al.
Publicado: (2026)

Assessing the Quality of Life in Adult Lung Transplant Recipients Quality of Life Post‐Lung Transplant
por: Bashayer M. Al‐Shweeman, et al.
Publicado: (2025)

Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium
por: Paulo Lisboa Bittencourt, et al.
Publicado: (2024)

Intraoperative Cardiac Arrests in Asian Recipients of Liver Transplantation—Second Report After Learning Curve
por: Jisun Choi, et al.
Publicado: (2024)

Association of Sedentary Behavior and Physical Activity With the Risk of Post‐Transplant Diabetes Mellitus Among Living Donor Liver Transplant Recipients: A Cross‐Sectional Isotemporal Substitution Analysis
por: Miyuki Ushio, et al.
Publicado: (2025)

Abdominal Gynecologic Procedures in Pancreas Transplant Recipients
por: Allison Drury, et al.
Publicado: (2024)

Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
por: Madhumita Rao, et al.
Publicado: (2025)

Association Between Liver Graft to Recipient Weight Ratio and Acute Kidney Injury Following Liver Transplantation: A Historical Cohort Study
por: Maxime Soucy‐Proulx, et al.
Publicado: (2024)

Interplay of Donor–Recipient Relationship and Donor Race in Living Liver Donation in the United States
por: Abdula Al‐Seraji, et al.
Publicado: (2024)

Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation—A European Registry Study
por: Milan J. Sonneveld, et al.
Publicado: (2024)

The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
por: Qingyong Xu, et al.
Publicado: (2026)

Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
por: Armaan F. Akbar, et al.
Publicado: (2024)

Travel Practices and Associated Risks in Adult Thoracic Transplant Recipients: A Monocentric Survey
por: Benoît Henry, et al.
Publicado: (2025)

Serum β2‐Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients
por: Sandesh Parajuli, et al.
Publicado: (2024)

Risk Factors and Outcomes Associated With the Development of Persistent Acute Kidney Injury in Non‐Renal Solid Organ Transplant Recipients: Systematic Review and Meta‐Analysis
por: Ivan E. Saraiva, et al.
Publicado: (2024)

Correction to “A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients is Feasible and Associated With Lower Post‐Transplant Relapse”
Publicado: (2025)

Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation
por: Javier M. Zamora‐Olaya, et al.
Publicado: (2024)

Comparison of Sarcopenia Assessment in Liver Transplant Recipients by Computed Tomography Freehand Region‐of‐Interest versus an Automated Deep Learning System
por: William Miller, et al.
Publicado: (2025)